|
1
|
Bray F, Jemal A, Grey N, Ferlay J and
Forman D: Global cancer transitions according to the Human
Development Index (2008–2030): A population-based study. Lancet
Oncol. 13:790–801. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ding Y, Yang M, She S, Min H, Xv X, Ran X,
Wu Y, Wang W, Wang L, Yi L, et al: iTRAQ-based quantitative
proteomic analysis of cervical cancer. Int J Oncol. 46:1748–1758.
2015.PubMed/NCBI
|
|
3
|
Smith HO, Tiffany MF, Qualls CR and Key
CR: The rising incidence of adenocarcinoma relative to squamous
cell carcinoma of the uterine cervix in the United States - a
24-year population-based study. Gynecol Oncol. 78:97–105. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gascoigne KE and Taylor SS: Cancer cells
display profound intra- and interline variation following prolonged
exposure to antimitotic drugs. Cancer Cell. 14:111–122. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rein DT and Kurbacher CM: The role of
chemotherapy in invasive cancer of the cervix uteri: Current
standards and future prospects. Anticancer Drugs. 12:787–795. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chiappedi M and Bejor M: Herbals and
natural dietary supplements in psychiatric practice. Recent Patents
CNS Drug Discov. 5:164–171. 2010. View Article : Google Scholar
|
|
7
|
Sidhu GS, Mani H, Gaddipati JP, Singh AK,
Seth P, Banaudha KK, Patnaik GK and Maheshwari RK: Curcumin
enhances wound healing in streptozotocin induced diabetic rats and
genetically diabetic mice. Wound Repair Regen. 7:362–374. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Niederau C and Göpfert E: The effect of
chelidonium- and turmeric root extract on upper abdominal pain due
to functional disorders of the biliary system. Results from a
placebo-controlled double-blind study. Med Klin (Munich).
94:425–430. 1999.In German. View Article : Google Scholar
|
|
9
|
Duvoix A, Blasius R, Delhalle S,
Schnekenburger M, Morceau F, Henry E, Dicato M and Diederich M:
Chemopreventive and therapeutic effects of curcumin. Cancer Lett.
223:181–190. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Thiagarajan R and Manikandan R:
Antioxidants and cataract. Free Radic Res. 47:337–345. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Basnet P and Skalko-Basnet N: Curcumin: An
anti-inflammatory molecule from a curry spice on the path to cancer
treatment. Molecules. 16:4567–4598. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kunnumakkara AB, Anand P and Aggarwal BB:
Curcumin inhibits proliferation, invasion, angiogenesis and
metastasis of different cancers through interaction with multiple
cell signaling proteins. Cancer Lett. 269:199–225. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shehzad A, Wahid F and Lee YS: Curcumin in
cancer chemoprevention: Molecular targets, pharmacokinetics,
bioavailability, and clinical trials. Arch Pharm (Weinheim).
343:489–499. 2010. View Article : Google Scholar
|
|
14
|
Bava SV, Puliappadamba VT, Deepti A, Nair
A, Karunagaran D and Anto RJ: Sensitization of taxol-induced
apoptosis by curcumin involves down-regulation of nuclear
factor-kappaB and the serine/threonine kinase Akt and is
independent of tubulin polymerization. J Biol Chem. 280:6301–6308.
2005. View Article : Google Scholar
|
|
15
|
Goel A, Kunnumakkara AB and Aggarwal BB:
Curcumin as 'Curecumin': From kitchen to clinic. Biochem Pharmacol.
75:787–809. 2008. View Article : Google Scholar
|
|
16
|
Strimpakos AS and Sharma RA: Curcumin:
Preventive and therapeutic properties in laboratory studies and
clinical trials. Antioxid Redox Signal. 10:511–545. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lu JJ, Cai YJ and Ding J: Curcumin induces
DNA damage and caffeine-insensitive cell cycle arrest in colorectal
carcinoma HCT116 cells. Mol Cell Biochem. 354:247–252. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Park C, Kim GY, Kim GD, Choi BT, Park YM
and Choi YH: Induction of G2/M arrest and inhibition of
cyclooxygenase-2 activity by curcumin in human bladder cancer T24
cells. Oncol Rep. 15:1225–1231. 2006.PubMed/NCBI
|
|
19
|
Tomita M, Kawakami H, Uchihara JN,
Okudaira T, Masuda M, Takasu N, Matsuda T, Ohta T, Tanaka Y,
Ohshiro K, et al: Curcumin (diferuloylmethane) inhibits
constitutive active NF-kappaB, leading to suppression of cell
growth of human T-cell leukemia virus type I-infected T-cell lines
and primary adult T-cell leukemia cells. Int J Cancer. 118:765–772.
2006. View Article : Google Scholar
|
|
20
|
Giri AK, Das SK, Talukder G and Sharma A:
Sister chromatid exchange and chromosome aberrations induced by
curcumin and tartrazine on mammalian cells in vivo. Cytobios.
62:111–117. 1990.PubMed/NCBI
|
|
21
|
Blasiak J, Trzeciak A and Kowalik J:
Curcumin damages DNA in human gastric mucosa cells and lymphocytes.
J Environ Pathol Toxicol Oncol. 18:271–276. 1999.
|
|
22
|
Cao J, Jia L, Zhou HM, Liu Y and Zhong LF:
Mitochondrial and nuclear DNA damage induced by curcumin in human
hepatoma G2 cells. Toxicol Sci. 91:476–483. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim B, Kim HS, Jung EJ, Lee JY, K Tsang B,
Lim JM and Song YS: Curcumin induces ER stress-mediated apoptosis
through selective generation of reactive oxygen species in cervical
cancer cells. Mol Carcinog. 55:918–928. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lewinska A, Adamczyk J, Pajak J, Stoklosa
S, Kubis B, Pastuszek P, Slota E and Wnuk M: Curcumin-mediated
decrease in the expression of nucleolar organizer regions in
cervical cancer (HeLa) cells. Mutat Res Genet Toxicol Environ
Mutagen. 771:43–52. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Singh M and Singh N: Molecular mechanism
of curcumin induced cytotoxicity in human cervical carcinoma cells.
Mol Cell Biochem. 325:107–119. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sreekanth CN, Bava SV, Sreekumar E and
Anto RJ: Molecular evidences for the chemosensitizing efficacy of
liposomal curcumin in paclitaxel chemotherapy in mouse models of
cervical cancer. Oncogene. 30:3139–3152. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang AC, Lin TP, Weng YS, Ho YT, Lin HJ,
Huang LJ, Kuo SC and Chung JG: Ethyl
2-[N-m-chlorobenzyl-(2′-methyl)]
anilino-4-oxo-4,5-dihydrofuran-3-carboxylate (JOT01006) induces
apoptosis in human cervical cancer HeLa cells. Anticancer Res.
27:2505–2514. 2007.PubMed/NCBI
|
|
28
|
Leung YM, Wong KL, Chen SW, Lu DY, Kuo CS,
Chen YR, Chen YW and Cheng TH: Down-regulation of voltage-gated
Ca2+ channels in Ca2+ store-depleted rat
insulinoma RINm5F cells. Biomedicine. 3:130–139. 2013. View Article : Google Scholar
|
|
29
|
Lin MC, Tsai SY, Wang FY, Liu FH, Syu JN
and Tang FY: Leptin induces cell invasion and the upregulation of
matrilysin in human colon cancer cells. Biomedicine. 3:174–180.
2013. View Article : Google Scholar
|
|
30
|
Wu LY, Lu HF, Chou YC, Shih YL, Bau DT,
Chen JC, Hsu SC and Chung JG: Kaempferol induces DNA damage and
inhibits DNA repair associated protein expressions in human
promyelocytic leukemia HL-60 cells. Am J Chin Med. 43:365–382.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Błasiak J, Trzeciak A, Małecka-Panas E,
Drzewoski J, Iwanienko T, Szumiel I and Wojewódzka M: DNA damage
and repair in human lymphocytes and gastric mucosa cells exposed to
chromium and curcumin. Teratog Carcinog Mutagen. 19:19–31. 1999.
View Article : Google Scholar
|
|
32
|
Ashby J, Tinwell H, Lefevre PA and Browne
MA: The single cell gel electrophoresis assay for induced DNA
damage (comet assay): Measurement of tail length and moment.
Mutagenesis. 10:85–90. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pool-Zobel BL, Lotzmann N, Knoll M,
Kuchenmeister F, Lambertz R, Leucht U, Schröder HG and Schmezer P:
Detection of genotoxic effects in human gastric and nasal mucosa
cells isolated from biopsy samples. Environ Mol Mutagen. 24:23–45.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Marchissio MJ, Francés DE, Carnovale CE
and Marinelli RA: Evidence for necrosis, but not apoptosis, in
human hepatoma cells with knockdown of mitochondrial aquaporin-8.
Apoptosis. 19:851–859. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zheng B, Wu L, Ma L, Liu S, Li L, Xie W
and Li X: Telekin induces apoptosis associated with the
mitochondria-mediated pathway in human hepatocellular carcinoma
cells. Biol Pharm Bull. 36:1118–1125. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Olive PL, Banáth JP and Durand RE:
Detection of etoposide resistance by measuring DNA damage in
individual Chinese hamster cells. J Natl Cancer Inst. 82:779–783.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tice RR, Andrews PW and Singh NP: The
single cell gel assay: A sensitive technique for evaluating
intercellular differences in DNA damage and repair. Basic Life Sci.
53:291–301. 1990.PubMed/NCBI
|
|
38
|
Malhotra P, Adhikari M, Singh SK and Kumar
R: N-acetyl tryptophan glucopyranoside (NATG) provides
radioprotection to murine macrophage J774A.1 cells. Free Radic Res.
49:1488–1498. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Banzai C, Nishino K, Quan J, Yoshihara K,
Sekine M, Yahata T and Tanaka K; Gynecological Cancer Registry of
Niigata: Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A
genes in cervical carcinoma. Int J Clin Oncol. 19:127–132. 2014.
View Article : Google Scholar
|
|
40
|
Huang J, Ye F, Chen H, Lu W and Xie X:
Amino acid substitution polymorphisms of the DNA repair gene MGMT
and the susceptibility to cervical carcinoma. Carcinogenesis.
28:1314–1322. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Verbeek B, Southgate TD, Gilham DE and
Margison GP: O6-Methylguanine-DNA methyltransferase
inactivation and chemotherapy. Br Med Bull. 85:17–33. 2008.
View Article : Google Scholar
|
|
42
|
Christmann M, Verbeek B, Roos WP and Kaina
B: O(6)-Methylguanine-DNA methyltransferase (MGMT) in normal
tissues and tumors: Enzyme activity, promoter methylation and
immunohistochemistry. Biochim Biophys Acta. 1816:179–190.
2011.PubMed/NCBI
|
|
43
|
Dueñas-González A, Lizano M, Candelaria M,
Cetina L, Arce C and Cervera E: Epigenetics of cervical cancer. An
overview and therapeutic perspectives. Mol Cancer. 4:382005.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Abramovitch S, Glaser T, Ouchi T and
Werner H: BRCA1-Sp1 interactions in transcriptional regulation of
the IGF-IR gene. FEBS Lett. 541:149–154. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Maor SB, Abramovitch S, Erdos MR, Brody LC
and Werner H: BRCA1 suppresses insulin-like growth factor-I
receptor promoter activity: Potential interaction between BRCA1 and
Sp1. Mol Genet Metab. 69:130–136. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Taron M, Rosell R, Felip E, Mendez P,
Souglakos J, Ronco MS, Queralt C, Majo J, Sanchez JM, Sanchez JJ,
et al: BRCA1 mRNA expression levels as an indicator of
chemoresistance in lung cancer. Hum Mol Genet. 13:2443–2449. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lou Z, Minter-Dykhouse K, Franco S,
Gostissa M, Rivera MA, Celeste A, Manis JP, van Deursen J,
Nussenzweig A, Paull TT, et al: MDC1 maintains genomic stability by
participating in the amplification of ATM-dependent DNA damage
signals. Mol Cell. 21:187–200. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Amichay K, Kidron D, Attias-Geva Z,
Schayek H, Sarfstein R, Fishman A, Werner H and Bruchim I: BRCA1 is
expressed in uterine serous carcinoma (USC) and controls
insulin-like growth factor I receptor (IGF-IR) gene expression in
USC cell lines. Int J Gynecol Cancer. 22:748–754. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Prives C and Hall PA: The p53 pathway. J
Pathol. 187:112–126. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Gorgoulis VG, Zacharatos P, Mariatos G,
Liloglou T, Kokotas S, Kastrinakis N, Kotsinas A, Athanasiou A,
Foukas P, Zoumpourlis V, et al: Deregulated expression of c-mos in
non-small cell lung carcinomas: Relationship with p53 status,
genomic instability, and tumor kinetics. Cancer Res. 61:538–549.
2001.PubMed/NCBI
|
|
51
|
Bonner WM, Redon CE, Dickey JS, Nakamura
AJ, Sedelnikova OA, Solier S and Pommier Y: GammaH2AX and cancer.
Nat Rev Cancer. 8:957–967. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Celeste A, Petersen S, Romanienko PJ,
Fernandez-Capetillo O, Chen HT, Sedelnikova OA, Reina-San-Martin B,
Coppola V, Meffre E, Difilippantonio MJ, et al: Genomic instability
in mice lacking histone H2AX. Science. 296:922–927. 2002.
View Article : Google Scholar : PubMed/NCBI
|
